A61K 39/27
Equine rhinopneumonitis virus
A61K39/27 (Equine rhinopneumonitis virus) appears on 15 US grants and 8 published applications in this corpus.
Search patents in A61K- Granted patents
- 15
- Published applications
- 8
- Assignees
- 12
- Inventors
- 22
- Latest grant
- 13 Sep 2011
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1978 | 2 | 0 |
| 1979 | 0 | 0 |
| 1980 | 0 | 0 |
| 1981 | 0 | 0 |
| 1982 | 0 | 0 |
| 1983 | 0 | 0 |
| 1984 | 0 | 0 |
| 1985 | 0 | 0 |
| 1986 | 0 | 0 |
| 1987 | 0 | 0 |
| 1988 | 0 | 0 |
| 1989 | 0 | 0 |
| 1990 | 0 | 0 |
| 1991 | 0 | 0 |
| 1992 | 1 | 0 |
| 1993 | 0 | 0 |
| 1994 | 0 | 0 |
| 1995 | 0 | 0 |
| 1996 | 0 | 0 |
| 1997 | 0 | 0 |
| 1998 | 2 | 0 |
| 1999 | 0 | 0 |
| 2000 | 1 | 0 |
| 2001 | 2 | 0 |
| 2002 | 0 | 0 |
| 2003 | 1 | 2 |
| 2004 | 2 | 3 |
| 2005 | 0 | 1 |
| 2006 | 0 | 0 |
| 2007 | 2 | 1 |
| 2008 | 1 | 1 |
| 2009 | 0 | 0 |
| 2010 | 0 | 0 |
| 2011 | 1 | 0 |
By publication year. Applications have been published since 2001.
Recent patents
- gM-negative EHV-mutants13 Sep 2011US 8,017,317 B2Boehringer Ingelheim Vetmedica GmbH
- Method of identification of equine herpes virus type 1 causing neurological disease, method of producing a vaccine against neurological disease caused by equine herpes virus type 1, and vaccine against neurological disease caused by equine herpes virus type 129 Jan 2008US 7,323,178 B1The Ohio Department of Agriculture
- gM-negative EHV-mutants18 Dec 2007US 7,309,598 B2Boehringer Ingelheim Vetmedica GmbH
- Equine herpesvirus vaccine5 Jun 2007US 7,226,604 B2Boehringer Ingelheim Vetmedica GmbH
- Equine herpesvirus vaccine12 Oct 2004US 6,803,041 B2Boehringer Ingelheim Vetmedica GmbH
- Gm-negative ehv-mutants3 Jul 2008US 2008/0160046 A1Boehringer Ingelheim Vetmedica GmbH
- Equine herpesvirus vaccine23 Aug 2007US 2007/0196390 A1Boehringer Ingelheim Vetmedica GmbH
- Equine herpesvirus vaccine21 Apr 2005US 2005/0084502 A1Boehringer Ingelheim Vetmedica GmbH
- Equine herpes virus temperature sensitive mutant and live vaccine thereof24 Jun 2004US 2004/0120972 A1
- Equine herpes virus temperature sensitive mutant and live vaccine thereof22 Apr 2004US 2004/0076642 A1
Most cited
By later US patents
- Equine Rhinopneumonitis Virus17US 4,110,433 APhilips Roxane, Inc. · 1978
- Method of identification of equine herpes virus type 1 causing neurological disease, method of producing a vaccine against neurological disease caused by equine herpes virus type 1, and vaccine against neurological disease caused by equine herpes virus type 112US 7,323,178 B1The Ohio Department of Agriculture · 2008
- Recombinant equine herpesviruses10US 5,741,696 ASyntro Corporation · 1998
- Polynucleotide formulation against pathologies of the horse9US 6,207,166 B1Merial Limited · 2001
- Inactivated equine rhinopneumonitis virus vaccine and use thereof8US 4,083,958 AUniversity of Kentucky Research Foundation · 1978